
New treatment for hormone refractory prostate cancer
I am seeking to find out what are the new drug therapies in
development and/or clinical trials for treatment of hormone refractory
prostate cancer. In other words, after Lupron or Casodex no longer
has therapeutic effect, what therapies are under research by companies
in the US, Europe or Japan.
Please respond to John Donovan